Genprex Inc (GNPX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access GNPX Annual Balance Sheets →
By examining balance sheet figures across successive periods, users can identify shifts in Genprex Inc's financial structure and capital allocation.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent15.15
Cash & Short-term Investments15.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.69
Total Current Assets15.84
Other Assets, Noncurrent1.29
Research And Development Assets Noncurrent1.50
Total Assets17.14
Liabilities
Accounts Payable and Accrued Liabilities, Current LI0.29
Derivative Liability LI0.02
Other Liabilities, Current2.03
Total Current Liabilities2.34
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Total Liabilities2.34
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock194.73
Retained Earnings / Accumulated Deficit-179.94
Other Equity0.00
Common Stockholder's Equity14.80
Total Stockholder's Equity14.80
Liabilities & Stockholder's Equity17.14
4 historic quarters locked

Sign in to unlock the full Genprex Inc balance sheet history.

About Genprex Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001437749-26-027846

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.